HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Proposed Combat Meth Compliance Fee Would Be Waived For Many Retailers

This article was originally published in The Tan Sheet

Executive Summary

Businesses already paying to support the Drug Enforcement Administration's Diversion Control Program would be exempt from paying an additional fee to certify they have trained employees on compliance with the Combat Meth Act, DEA says in a proposed rule

You may also be interested in...

FDA’s Agenda Slates September For Cough/Cold Proposal, Sunscreen Rule

Meeting deadlines on regulatory agenda actions, such as finalizing OTC monographs, could be a higher priority for FDA under its new management

Distributions Of All Amounts Of PSE Would Be Regulated Under DEA Rule

The Drug Enforcement Administration continues developing enforcement tools to implement the Combat Meth Act with a Nov. 20 notice of proposed rulemaking to regulate the distribution of all amounts of pseudoephedrine and phenylpropanolamine

Combat Meth Act Compliance Can Trip Up Drug Retailers

Complying with the nationwide limit the Combat Meth Act set on sales of pseudoephedrine-containing OTCs is simpler than handling separate state or local laws, but retailers' responsibilities under the act have not been easily met, the head of a Montana pharmacy chain tells the Senate Finance Committee

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts